Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies

SourceYahoo Finance
Date Published06/26/2023

Additional Reshoring Information:

Company/Division name Lonza
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):300
Year reshoring announced:2023
Domestically, the work will be done:In-house
Country(ies) from which reshored:Switzerland
City reshored to:Portsmouth
State(s) reshored to:NH
If relevant, work nearshored to:-
Product(s) reshoredcell therapies
What domestic positive factors made reshoring more attractive?Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles